MYC and ovarian carcinoma: As expected, our data clearly showed that the expressions of both Cyclin-D1 and C-myc were upregulated by PITX2even in tumor tissues obtained from tumor xenograft mice, whereasPITX2 depleted ovarian cancer cells exhibited reduction in the expressions of Cyclin-D1 and C-myc.